Companies
HQLondon, UK
Employees1-10
Funding$50.6M
1 active role
Healthcare AIFoundation Model ProviderB2B SaaSSeries A$50M-$200M
About
Manas AI is a seed-stage AI-native drug discovery company focused on cancer and rare diseases. It builds foundational AI models integrated with chemistry, physics, and biology to accelerate target identification, candidate generation, and preclinical development across multiple modalities, offering a platform for drug discovery to pharma/biotech researchers and monetizing via platform-based offerings and services.
Active Roles
1Key Investors
General Catalyst, Greylock, Mosaic Ventures, Reid Hoffman